[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Ozmosi [@OzmosiHealth](/creator/twitter/OzmosiHealth) on x 2627 followers Created: 2025-07-10 18:32:25 UTC Novartis reaches agreement with pan-Canadian Pharmaceutical Alliance on Cosentyx® for hidradenitis suppurativa (HS) treatment. More Info: $XBI $IBB $XPH $PPH  XXX engagements  **Related Topics** [$pph](/topic/$pph) [$xph](/topic/$xph) [$ibb](/topic/$ibb) [$xbi](/topic/$xbi) [more info](/topic/more-info) [novartis](/topic/novartis) [$novnsw](/topic/$novnsw) [stocks healthcare](/topic/stocks-healthcare) [Post Link](https://x.com/OzmosiHealth/status/1943377786565226935)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Ozmosi @OzmosiHealth on x 2627 followers
Created: 2025-07-10 18:32:25 UTC
Novartis reaches agreement with pan-Canadian Pharmaceutical Alliance on Cosentyx® for hidradenitis suppurativa (HS) treatment.
More Info: $XBI $IBB $XPH $PPH
XXX engagements
Related Topics $pph $xph $ibb $xbi more info novartis $novnsw stocks healthcare
/post/tweet::1943377786565226935